Is AMD Stock an All-Time Buy?
Advanced Micro Devices (NASDAQ:AMD) is a high-growth AI stock that…
Sell
46
FA Quote, Financials, Valuation and Earnings
Last price:
$18.54
Seasonality move
:
2.16%
Day range:
$18.50 - $18.95
52-week range:
$14.01 - $20.79
Dividend yield:
0%
P/E ratio:
630.33x
P/S ratio:
3.62x
P/B ratio:
3.55x
Volume:
218.4K
Avg. volume:
1M
1-year change:
15.02%
Market cap:
$3.3B
Revenue:
$763.8M
EPS (TTM):
$0.03
Analysts' Opinion
-
Consensus RatingFirst Advantage has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 3 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $17.92, First Advantage has an estimated upside of 15.46% from its current price of $18.91.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $15.50 representing 100% downside risk from its current price of $18.91.
Fair Value
-
According to the consensus of 6 analysts, First Advantage has 15.46% upside to fair value with a price target of $17.92 per share.
FA vs. S&P 500
-
Over the past 5 trading days, First Advantage has underperformed the S&P 500 by -3.5% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
First Advantage does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
First Advantage revenues have been falling on a year-over-year basis for 7 quarters in a row. In the most recent quarter First Advantage reported revenues of $199.1M.
Earnings Growth
-
First Advantage earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter First Advantage reported earnings per share of -$0.06.
Enterprise value:
3.5B
EV / Invested capital:
2.38x
Price / LTM sales:
3.62x
EV / EBIT:
73.78x
EV / Revenue:
4.65x
PEG ratio (5yr expected):
--
EV / Free cash flow:
24.82x
Price / Operating cash flow:
19.32x
Enterprise value / EBITDA:
20.60x
Gross Profit (TTM):
$373.9M
Return On Assets:
0.3%
Net Income Margin (TTM):
0.65%
Return On Equity:
0.54%
Return On Invested Capital:
0.34%
Operating Margin:
4.58%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $810M | $773.8M | $755.6M | $200.4M | $199.1M | |
| Gross Profit | $401.7M | $380.4M | $373.9M | $99M | $98.2M | |
| Operating Income | $90.9M | $80.9M | $47.7M | $23.2M | $9.1M | |
| EBITDA | $230.4M | $212.3M | $170.8M | $55.6M | $39.3M | |
| Diluted EPS | $0.39 | $0.28 | $0.03 | $0.07 | -$0.06 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $443.5M | $571.5M | $349.3M | $467M | |
| Total Assets | -- | $1.9B | $1.9B | $1.6B | $1.7B | |
| Current Liabilities | -- | $99.3M | $101.6M | $94.8M | $121.4M | |
| Total Liabilities | -- | $742.5M | $761.9M | $741.4M | $736.4M | |
| Total Equity | -- | $1.1B | $1.2B | $888M | $920.7M | |
| Total Debt | -- | $554.4M | $556.2M | $558M | $559.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $207.7M | $176M | $170.6M | $34.4M | $43.5M | |
| Cash From Investing | -$88M | -$70M | -$26.6M | -$48.6M | -$7.9M | |
| Cash From Financing | -$1.4M | -$328.9M | -$1.8M | -$219.6M | $942K | |
| Free Cash Flow | $179.2M | $149.3M | $141.7M | $26.9M | $35.6M | |
FA
Sector
Market Cap
$3.3B
$770.7M
Price % of 52-Week High
90.96%
79.02%
Dividend Yield
0%
0%
Shareholder Yield
--
2.31%
1-Year Price Total Return
15.02%
-1.97%
Beta (5-Year)
--
0.898
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
5.44%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Buy
Level
$18.84
200-day SMA
Buy
Level
$17.53
Bollinger Bands (100)
Buy
Level
17.96 - 19.8
Chaikin Money Flow
Sell
Level
-11.4M
20-day SMA
Sell
Level
$19.31
Relative Strength Index (RSI14)
Sell
Level
48.25
ADX Line
Sell
Level
23.23
Williams %R
Neutral
Level
-67.8322
50-day SMA
Buy
Level
$18.81
MACD (12, 26)
Sell
Level
-0.06
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Sell
Level
-179.7K
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.7957)
Buy
CA Score
(Annual)
Level (0.2732)
Buy
Beneish M-Score
(Annual)
Level (-2.856)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.2184)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Sell
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
First Advantage Corp is a provider of employment background screening and verification solutions. The company delivers services and insights that help its customers manage risk and hire talent. The Company has two reportable segments, Americas and International. The Americas segment provides technology solutions for screening, verifications, safety, and compliance in the United States, Canada, and Latin America markets. and the International segment provides technology solutions for screening, verifications, safety, and compliance outside of the Americas. The company derives its maximum revenue from America.
Stock Forecast FAQ
In the current month, FA has received 3 Buy ratings 3 Hold ratings, and 0 Sell ratings. The FA average analyst price target in the past 3 months is $17.92.
-
Where Will First Advantage Stock Be In 1 Year?
According to analysts, the consensus estimate is that First Advantage share price will rise to $17.92 per share over the next 12 months.
-
What Do Analysts Say About First Advantage?
Analysts are divided on their view about First Advantage share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that First Advantage is a Sell and believe this share price will drop from its current level to $15.50.
-
What Is First Advantage's Price Target?
The price target for First Advantage over the next 1-year time period is forecast to be $17.92 according to 6 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is FA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for First Advantage is a Leans Bullish. 3 of 6 analysts rate the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of FA?
You can purchase shares of First Advantage via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase First Advantage shares.
-
What Is The First Advantage Share Price Today?
First Advantage was last trading at $18.54 per share. This represents the most recent stock quote for First Advantage. Yesterday, First Advantage closed at $18.91 per share.
-
How To Buy First Advantage Stock Online?
In order to purchase First Advantage stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
How High Will Airbnb Stock Go?
Airbnb, Inc. (NASDAQ:ABNB) share price has seen substantial turbulence over…
Why Is SoundHound AI Stock Up So Much?
Like many companies improving AI technologies and exploring ways to…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 43x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
57
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
64
ARQQ alert for Dec 27
Arqit Quantum [ARQQ] is down 7.51% over the past day.
Buy
64
QMCO alert for Dec 27
Quantum [QMCO] is up 1.83% over the past day.
Buy
65
ALGS alert for Dec 27
Aligos Therapeutics [ALGS] is down 3.46% over the past day.
